9MJ3
Crystal structure of the VRC01-class antibody 12A01, derived from GT1.1 vaccination, in complex with eOD-GT8
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | NSLS-II BEAMLINE 17-ID-1 |
Synchrotron site | NSLS-II |
Beamline | 17-ID-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2024-09-25 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 0.920 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 53.687, 72.364, 218.618 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 33.900 - 2.200 |
R-factor | 0.2184 |
Rwork | 0.217 |
R-free | 0.24550 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.002 |
RMSD bond angle | 0.527 |
Data reduction software | autoPROC |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.21.2_5419) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 33.900 | 2.240 |
High resolution limit [Å] | 2.200 | 2.200 |
Number of reflections | 44221 | 2169 |
<I/σ(I)> | 10.6 | |
Completeness [%] | 99.9 | |
Redundancy | 13.8 | |
CC(1/2) | 0.990 | 0.800 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 1.2M sodium dihydrogen phosphate, 0.1M CAPS, 0.8M di-potassium hydrogen phosphate, 25% glycerol, 0.2M lithium sulfate |